TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Abera Bioscience AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,680
|
0
|
1,161 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-16,935
|
-18,332
|
-8,938 |
EBITDA |
-17,018
|
-18,344
|
-8,937 |
Total assets |
9,472
|
18,515
|
30,597 |
Current assets |
7,535
|
16,729
|
12,128 |
Current liabilities |
3,740
|
2,644
|
2,166 |
Equity capital |
5,732
|
15,871
|
28,431 |
- share capital |
1,172
|
977
|
816 |
Employees (average) |
6
![]() |
6
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.5%
|
85.7%
|
92.9% |
Turnover per employee |
447
|
0
|
232 |
Profit as a percentage of turnover | -631.9% | -769.9% | |
Return on assets (ROA) |
-178.8%
|
-99.0%
|
-29.2% |
Current ratio |
201.5%
|
632.7%
|
559.9% |
Return on equity (ROE) |
-295.4%
|
-115.5%
|
-31.4% |
Change turnover |
2,680
|
-1,126
|
1,161 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.